$XBIO Income Statement | Understand Stock

$XBIO

$1.85 +$0.13 (7.56%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Royalty revenue
Revenue
Royalty
Total revenue

Operating costs and expenses:
Research and development
General and administrative
Asset impairment charges (Note 6)
Total operating costs and expenses
Loss from operations
Other income (expense):
Other income (expense)
Interest income, net
Total other income, net
Loss before income taxes
Income tax benefit

Net loss
Basic and diluted net loss per share
Weighted-average shares of common stock outstanding, basic and diluted
Basic net loss per share
Diluted net loss per share
Weighted-average shares of common stock outstanding, basic
Weighted-average shares of common stock outstanding, diluted

Comments